Facebook
X
LinkedIn
Forward28th IQVIA Controlled Substances and State Regulatory Conference - Mixing With DEA in Mind: Compliance Considerations for Controlled Substance Compounding
The industry’s most trusted compliance conference returns.
Amid constantly evolving state and federal regulations and changing enforcement approaches, stay informed about the newest, most efficient, and cost-appropriate compliance.
Recognized for over 25 years as the leading annual event in Controlled Substances and State Regulatory Compliance, this year’s 28th conference will once again deliver comprehensive legal, regulatory, and industry insights. Join us for engaging discussions on the latest initiatives and challenges in controlled-substance, listed-chemical, and state regulatory compliance, featuring insights and expertise from leading industry professionals, regulatory authorities, and prominent law firms. You’ll also benefit from valuable networking opportunities to connect with peers, exchange meaningful insights, and discover practical solutions designed to support your organization’s ongoing compliance strategies.
If you have not registered for the conference, you can do so here: Home - 28th Annual Controlled Substances & State Regulatory Conference
Once you are registered with IQVIA, return here to complete your registration for the ACPE-accredited continuing education course. After the live program, complete the required course components and claim your credit.
Compounding medications is an everyday occurrence in most pharmacies, but there are extra precautions that have to be taken when you compound controlled substances. This session discusses processes you should have for controlled substance compounding in your facility as well when using external compounding pharmacies, as well as reviewing the DEA's stance on several key compounding topics.
Target Audience
This knowledge-based course is intended for Pharmacists (ACPE).
Learning Objectives
- Identify common diversion vulnerabilities throughout the compounding process.
- Discuss practical strategies to prevent and recognize diversion.
- Review DEA regulations as they relate to compounding controlled substances.
Course summary
- 1.00 ACPE PharmacyAuburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide.
September 17, 2026
Diversion in Context: Connecting Data, Culture, and Accountability
9:45 AM-10:45 AM
Pharmacy
Seville - Concurrent Education Sessions
1.0-hour ACPE Pharmacy credit available
Diversion in Context challenges pharmacists to move beyond isolated data points and view diversion through a broader operational, clinical, and human lens. This session explores how automated dispensing cabinet activity, analytics platforms, inventory discrepancies, and investigation findings must be interpreted within real-world workflow, staffing pressures, and system design. Attendees will learn how to connect data with policy, culture, and accountability to identify true risk, avoid false conclusions, and strengthen diversion prevention programs. Practical examples will illustrate how pharmacists can use context to improve decision-making, support frontline teams, and build sustainable, high-reliability diversion oversight.
Objectives
By the end of this session, the attendee will be able to:
- Describe how diversion data from automated dispensing cabinets, inventory reports, and surveillance tools should be interpreted within clinical workflow, staffing models, and operational context.
- Analyze diversion signals using a multidimensional framework that integrates policy, technology, and human factors to distinguish true risk from false positives.
- Apply contextual decision-making strategies to strengthen pharmacy-led diversion prevention oversight, improve interdisciplinary collaboration, and support sustainable compliance practices.
Linda Gordon
Senior Pharmacy Consultant, Regulatory Compliance Support (Regs)
HCA Healthcare
Pharmacists Aren't the Telemedicine Police: But You Will Be Treated Like You Are
11:00 AM-12:00 PM
Pharmacy
Seville - Concurrent Education Sessions
1.0-hour ACPE Pharmacy credit available
Telemedicine has transformed how controlled substances are prescribed — and how pharmacies are scrutinized. Pharmacists didn't sign up to police online prescribers, but the DEA, state boards, and PBMs expect exactly that. This session breaks down the "corresponding responsibility" doctrine in the telemedicine era, from Ryan Haight Act compliance and EPCS verification to red flag recognition and encounter validation. Attendees will leave with practical, ready-to-use SOPs, checklists, and documentation templates — the same tools your pharmacy needs to fill telemedicine prescriptions confidently, defend against audits, and stay off regulators' radar.
Mark Boesen
Pharm.D., J.D., Founding Partner
Boesen & Snow Law
Recent Fifth Circuit Ruling - Rejecting DEA's Interpretation of Corresponding Responsibility Regulation
2:15 PM-3:15 PM
Pharmacy
Seville - Concurrent Education Sessions
1.0-hour ACPE Pharmacy credit available
This session will review DEA's longstanding interpretation of the corresponding responsibility regulation and the dramatic shift in the traditional standards for enforcing corresponding responsibility on pharmacists related to controlled substance dispensing.
Roger Morris
RPh, JD, Partner and Member of the Executive Committee
Quarles & BradyLLP
Mixing With DEA in Mind: Compliance Considerations for Controlled Substance Compounding
3:30 PM-4:30 PM
Pharmacy
Seville - Concurrent Education Sessions
1.0-hour ACPE Pharmacy credit available
Compounding medications is an every day occurrence in most pharmacies, but there are extra precautions that have to be taken when you compound controlled substances. This session discusses processes you should have for controlled substance compounding in your facility as well when using external compounding pharmacies, as well as reviewing the DEA's stance on several key compounding topics.
Objectives
At the end of this presentation, attendees will:
- Identify common diversion vulnerabilities throughout the compounding process.
- Discuss practical strategies to prevent and recognize diversion.
- Review DEA regulations as they relate to compounding controlled substances.
Deepika Nayyar
Network Manager, Pharmacy Quality, Regulatory, Compliance, & Accreditation
Hackensack Meridian Health
Karla Palmer
Director
Hyman, Phelps & McNamara
September 18, 20126
Mitigating Risk & Preserving Reputation During a DEA Investigation
9:45 AM-10:45 AM
General
Valencia Ballroom
1.0-hour ACPE Pharmacy credit available
This session will focus on best practices in formulating a response and internal investigation plan in the face of a DEA investigation and pending enforcement action, including coordinating with outside counsel and consultants.
Objectives
- Understand the legal obligations necessary to ensure compliance with a government subpoena.
- Discover how to leverage outside counsel to conduct an internal investigation and ensure attorney-client privilege.
- Learn how to work for "cooperation credit" while putting up a zealous defense.
Andrew Hull
Director
Hyman Phelps & McNamara
A copy of the presentation slides will be located within the course content. Once you have registered for the course, please navigate to the 'Take Course' tab and click the navy blue 'Take Course' button. Navigate to the 'Course Materials' section of the course using the left-hand menu and download a PDF version of the program presentation. Course Materials will be added to the course the week of the live event.
Deepika Nayyar is an experienced pharmacy leader specializing in regulatory compliance, medication safety, and controlled substance diversion prevention within complex healthcare systems. Currently serving as Network Manager for Pharmacy Quality, Regulatory Compliance, and Accreditation at Hackensack Meridian Health, Deepika led the development and implementation of a comprehensive, system-wide Drug Diversion Prevention Program, integrating regulatory requirements, surveillance technologies, and multidisciplinary collaboration to strengthen controlled substance security and accountability. Deepika has extensive experience aligning pharmacy operations with state and federal regulations as well as accreditation standards, ensuring continuous survey readiness and risk mitigation across multiple facilities. A Board Certified Pharmacotherapy Specialist (BCPS) and Certified Diabetes Care and Education Specialist (CDCES), Deepika brings a strong clinical background in critical care, antimicrobial stewardship, and medication safety, supporting a proactive approach to diversion risk identification and prevention. Deepika's work continues to advance best practices in controlled substance management, patient safety, and regulatory excellence.
Karla Palmer serves as Director for Hyman, Phelps & McNamara. As a litigator with over 33 years’ experience, Karla advises clients throughout the pharmaceutical supply chain – from manufacturers and distributors to outsourcing facilities, pharmacies and doctors – on a range of legal and regulatory issues. These matters include DEA and FDA regulations and guidance, government inspections and investigations, Form 483 observations, warning letters, consent decrees, and administrative and federal proceedings. She represents entities and individuals in matters involving their DEA registration, including investigations, orders to show cause, immediate suspension matters, hearings and federal appeals of the same. Karla is a nationally recognized leader in the compounding space, both for Section 503A and 503B facilities. She regularly counsels clients on all aspects of compliance with state and federal statutes, regulations and guidance. Karla has written about and addressed industry audiences across the country on DEA and FDA and compliance, including all aspects of the passage and implementation of the 2013 Drug Quality and Security Act including both compounding and supply chain issues, its guidance documents, and implementing regulations.
Auburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide. The Universal Activity Number for this knowledge-based program is xxxxxx and is intended for pharmacists.
Disclosures: This program is offered through a collaboration with IQVIA. All presenters and others in control of content have no actual or potential conflict of interest in relation to this program.
Available Credit
- 1.00 ACPE PharmacyAuburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide.
Price
Please register through IQVIA for this program at: Home - 28th Annual Controlled Substances & State Regulatory Conference You will receive an access code to enroll in the CE program here.
Please click the navy blue TAKE COURSE button. This will automatically enroll you in the program and provide access to the course content, including COURSE INSTRUCTIONS, COURSE MATERIALS, and completion requirements to claim credit.